Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia

Hala Ibrahim Alhodaib; Sama Alsulihem

doi:10.4239/wjd.v12.i11.1908

Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia

World J Diabetes. 2021 Nov 15;12(11):1908-1916. doi: 10.4239/wjd.v12.i11.1908.

Authors

Hala Ibrahim Alhodaib¹, Sama Alsulihem²

Affiliations

¹ Community Health Sciences Department, King Saud University, Riyadh 11564, Saudi Arabia. halhodaib@ksu.edu.sa.
² College of Medicine, King Saud University, Riyadh 11564, Saudi Arabia.

Abstract

Background: In 2017, 35000 Saudi children and adolescents were living with a type 1 diabetes (T1D) diagnosis. Diabetic complications are minimized upon strengthened glycemic regulation. The annual cost of treating diabetic patients with complications was four-fold higher than for patients without complications. The use of flash glucose monitoring (FGM) enables better diabetes treatment and thereby improves glycemic control. Understanding the factors that affect effectiveness of FGM will help enhance the device's use and management of hospital resources, resulting in improved outcomes.

Aim: To investigate factors that affect effectiveness of the FGM system for glycated hemoglobin (HbA1c) levels/glycemic control among T1D patients.

Methods: A retrospective empirical analysis of T1D patient records from King Abdul-Aziz University Hospital and Prince Sultan Military Medical City was performed. T1D patients who began FGM between 2017 and 2019 were included.

Results: The data included 195 T1D patients (70 males and 125 females) with a mean age of 23.6 ± 8.1 years. Among them, 152 patients used multiple daily injection and 43 used an insulin pump. The difference in HbA1c level from baseline and after using FGM was -0.60 ± 2.10, with a maximum of 4.70 and a minimum of -6.30. There was a statistically significant negative correlation between the independent variables (age, duration of diabetes, level of engagement) and HbA1c. The group with the highest HbA1c mean (9.85) was 18-years-old, while the group with the lowest HbA1c mean (7.87) was 45-years-old. Patients with a low level of engagement (less than six scans per day) had the highest HbA1c mean (9.84), whereas those with a high level of engagement (more than eight scans per day) had the lowest HbA1c mean (8.33).

Conclusion: With proper education, FGM can help people with uncontrolled T1D over the age of 18 years to control their glucose level.

Keywords: Continuous glucose monitoring; Flash glucose monitoring; Glycemic control; Hypoglycemia; Type 1 diabetes.